Medicare will remove limits on PET scans used with new Alzheimer's drugs
Medicare will remove limits on covering PET scans used to help diagnose Alzheimer’s disease, allowing broader access to new treatments on the U.S. market. The Centers for Medicare and Medicaid Services (CMS) said in a memo it was removing a previous once-in-a-lifetime limit. But instead of making a broad decision about how many scans Medicare […]